Similar articles

• [Drug interactions. Proton pump inhibitors II].

  Zaigler M. Zaigler M. Internist (Berl). 1998 Sep;39(9):978-9. Internist (Berl). 1998. PMID: 9788120 German. No abstract available.
• [Proton pump inhibitors: Pantoprazole].

  Takeuchi K, Hase S. Takeuchi K, et al. Nihon Rinsho. 2002 Feb;60 Suppl 2:655-60. Nihon Rinsho. 2002. PMID: 11979865 Review. Japanese. No abstract available.
• Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.

  Becker TL, Maróstica M, Ribeiro ML, de Mendonça S, Gambero A, Pedrazzoli J Jr. Becker TL, et al. Int Immunopharmacol. 2004 Aug;4(8):1051-7. doi: 10.1016/j.intimp.2004.04.009. Int Immunopharmacol. 2004. PMID: 15222979
• Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.

  Giannini E, Romagnoli P, Fasoli A, Chiarbonello B, Malfatti F, Botta F, Risso D, Lantieri PB, Savarino V, Testa R. Giannini E, et al. Am J Gastroenterol. 2000 Oct;95(10):2762-7. doi: 10.1111/j.1572-0241.2000.03184.x. Am J Gastroenterol. 2000. PMID: 11051345 Clinical Trial.
• [Dosaging of proton pumps inhibitors].

  Brørs O. Brørs O. Tidsskr Nor Laegeforen. 2006 Sep 21;126(18):2397-9. Tidsskr Nor Laegeforen. 2006. PMID: 16998554 Review. Norwegian. No abstract available.